ADP private payrolls data missed expectations for March, but the revision upward of February's number seemed to slightly satisfy traders. General Motors CEO Mary Barra is back for more testimony in Washington on Wednesday, this time for the Senate. GM may be considering compensation for the families of those that died in their faulty cars. Mannkind stock is on a sugar high after the FDA panel voted in favor of the company's diabetes drug Afrezza. The FDA's final decision is on April 15.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.